icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Clinical Added Value
no clinical added value
NEVANAC 1 mg/ ml, eye drops, suspension does not offer any improvement in actual benefit (IAB V) over standard management of postoperative macular oedema associated with cataract surgery in diabetic patients.
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
ptW193qc4bhSBteL
Listen
